M&A due diligence · Digital health & life sciences
M&A Privacy & Security Due Diligence for Patient Engagement & Scheduling Apps
Sector consolidation, the kind driving WELL Health and Telus Health style roll-ups, has turned privacy due diligence from a closing formality into a deal-value question for booking and portal vendors. Whether you are being acquired or acquiring a smaller competitor, a buyer's team will pull consent records, check whether legacy clinic contracts ever named you as agent or electronic service provider, and map every sub-processor touching patient data. We run that review before a buyer does, or run it on your behalf against a target.
Reviewed by the Privacy Horizon team · Last reviewed
What you're protecting
What a buyer's diligence team actually inspects in a booking or portal company
The documents that matter most here are rarely the ones a general M&A checklist prioritizes, because they are specific to how this product handles custodian relationships.
Consent records across every clinic relationship
Whether a coherent, current consent record exists for patients across the clinics, hospitals and OHTs on the platform, or whether it varies contract by contract with gaps in between.
Legacy contracts missing agent or ESP language
Older clinic agreements signed before the product's privacy obligations were well understood often say nothing about agent or electronic service provider status, leaving the relationship undocumented.
Sub-processor and US routing disclosures
A clear, current list of every messaging, analytics and payment vendor touching patient data, and whether any of that routing was ever disclosed to the affected custodians.
Health information network provider agreements
Where the product connects multiple custodians, whether the written agreements a network provider role requires actually exist, or whether that status was never formally addressed.
PIA and TRA history
Whether privacy and threat and risk assessments exist for the clinics that needed them, particularly Alberta customers with their own filing obligation, and whether they were ever kept current.
Regulatory map
The regulatory record a diligence review checks
A buyer's counsel is not just checking whether you comply today; they are checking whether your documented history would hold up if a regulator asked the same questions.
Whether contracts actually establish PHIPA roles
A buyer wants to see that customer contracts clearly state whether you act as agent, electronic service provider or network provider, not language that leaves the question open.
Alberta PIA filings tied to acquired product lines
Where Alberta clinics are part of the customer base, a buyer checks whether the PIA filings those clinics needed were ever completed and whether support materials exist.
PIPEDA's breach record-keeping requirement
A 24-month record of past breaches and the organization's assessment of each one is something a buyer's team will ask to review directly as part of its own risk assessment.
Whether a BAA chain survives a change of ownership
For any US customer relationships, a buyer checks whether existing BAAs and their sub-processor chain transfer cleanly or need to be renegotiated as part of the deal.
What goes wrong
What erodes deal value in this sector's diligence
None of these findings necessarily kill a deal, but each one becomes a negotiating point, a price adjustment or a delay once a buyer's team finds it.
Consent records that do not survive a change of ownership
A consent basis built around the current corporate entity can become ambiguous the moment ownership changes, and a buyer will want that risk quantified before closing.
Contracts silent on agent or ESP status
A legacy clinic contract that never addressed your PHIPA role leaves both the buyer and the customer relationship on uncertain footing, exactly what diligence exists to surface early.
Undisclosed sub-processors surfacing late
A messaging or analytics vendor a buyer's team discovers only during technical diligence, rather than in your own documentation, reads as a governance gap even when the vendor itself is fine.
No PIA history for an Alberta-heavy customer base
A buyer weighing exposure in Alberta wants to see completed filings and support materials, not an assumption that clinics handled their own paperwork without help.
Our m&a due diligence for patient engagement & scheduling apps
What our M&A privacy diligence covers
The review is built for a multi-custodian booking or portal business specifically, whether you are the target or the acquirer.
Consent and contract record review
A structured audit of consent records and customer contracts across the platform, flagging where agent or ESP language is missing or inconsistent.
Regulatory posture review across provinces
An assessment of PHIPA, PIPEDA and any provincial obligations the customer base triggers, including Alberta PIA filings and BC or Quebec exposure.
Sub-processor and data-flow mapping
A current map of every vendor touching patient data and whether that routing was disclosed to the custodians whose data it carries.
A findings report built for negotiation
Clear, prioritized findings your deal team can use directly in price discussions or in structuring representations and warranties.
Integration planning support
Guidance on merging consent registers, contract templates and privacy programs after close, so gaps found in diligence get resolved rather than inherited quietly.
Buy-side target assessment
The same review run against a company you are considering acquiring, so the findings inform your offer rather than surfacing only after the deal closes.
How the engagement runs
How diligence runs, sell-side or buy-side
The approach adapts to which side of the deal you are on, but the underlying review covers the same ground.
Step 1
Scope the customer base and data flows
We map every clinic, hospital and OHT relationship, along with the vendors and integrations touching patient data, before reviewing a single document.
Step 2
Review contracts and consent records
Customer agreements, consent records and any existing PIAs or TRAs are checked against what current practice actually reflects.
Step 3
Assess regulatory exposure
Findings are weighed against PHIPA, PIPEDA, Alberta, BC and, where relevant, HIPAA obligations to size the actual risk, not just list gaps.
Step 4
Deliver findings for negotiation or integration
A clear report supports your deal team's negotiation on the sell side, or your integration plan once a target has been acquired.
What it costs
What M&A privacy diligence costs
Cost depends on how many custodian contracts and provinces are in scope, how much consent and PIA documentation already exists, and how tight the deal timeline is. A company with a handful of clean clinic contracts is a faster review than one with years of legacy agreements across several provinces.
Sell-side and buy-side engagements are scoped differently, since a sell-side review often runs against a fixed data-room deadline. Tell us your customer count, jurisdictions and timeline and we will quote the engagement accordingly.
Patient Engagement & Scheduling Apps: M&A due diligence questions, answered
Expect a buyer to check whether consent is documented consistently across every clinic relationship, whether contracts clearly state your role as agent, electronic service provider or network provider, and whether that consent basis survives a change of corporate ownership. Gaps here rarely kill a deal but commonly show up as price adjustments or negotiated holdbacks.
Start by inventorying which contracts are silent on your PHIPA role, since that is the specific gap most diligence reviews flag first. Where possible, amend the highest-value or longest-running contracts to state the role explicitly before going to market; where amendment is not realistic before closing, document the gap and its planned remediation so it reads as managed risk rather than an unknown.
Active consolidators buying companies in this space increasingly treat privacy documentation as a diligence line item with real weight, not a formality. A clean consent and contract record can support a smoother, faster close, while gaps tend to surface as specific price or structure adjustments rather than automatic deal breakers.
Existing health information network provider agreements generally need review to confirm they transfer with the business, or whether the change of ownership requires renegotiation with each connected custodian. This is exactly the kind of detail that gets missed without a dedicated review, since it sits outside a standard commercial contracts audit.
Before, wherever the timeline allows. Findings surfaced by your own review ahead of a sale can be remediated on your terms, while the same findings surfaced by a buyer's diligence team tend to become negotiating leverage against you instead.
Beyond the target's technical security posture, check whether their customer contracts actually establish a PHIPA role, whether consent records are consistent across their clinic base, and whether every sub-processor touching patient data has been disclosed. These are the specific items generic commercial diligence in this sector tends to miss.
More for patient engagement & scheduling apps
Other services for this niche
- Privacy & security for patient engagement & scheduling apps — overview
- Virtual CISO
- Virtual Privacy Officer
- Penetration Testing
- Incident Response Planning
- Privacy & Security Policy Development
- Privacy & Security Training
- Vendor Security Review & Questionnaire Support
- SOC 2 Readiness
- AI Privacy Impact Assessment
- HIPAA Readiness
About this service
What's Protecting Your Business from the Next Threat?
Don't wait for a breach to expose your vulnerabilities. Let Privacy Horizon secure your data, ensure compliance, and build lasting trust.